About This Event

ADMA Biologics, Inc. (Nasdaq: ADMA), a U.S. based, end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty biologics, visits the Nasdaq MarketSite in Times Square.

In honor of the occasion, Adam Grossman, ADMA’s Founder, President and Chief Executive Officer, rings the Opening Bell. Mr. Grossman will be joined by members of ADMA’s senior leadership team and board of directors to commemorate ADMA developing the first ever global yield enhancement for IVIG production processes, allowing for more product to meet unmet needs for patients in the United States.